These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38366849)

  • 1. Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?
    Basu A; Rais-Bahrami S
    J Natl Cancer Inst; 2024 May; 116(5):635-636. PubMed ID: 38366849
    [No Abstract]   [Full Text] [Related]  

  • 2. Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort.
    Shah Y; Kulm S; Nauseef JT; Chen Z; Elemento O; Kensler KH; Sharaf RN
    PLoS Comput Biol; 2024 Apr; 20(4):e1011990. PubMed ID: 38598551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bringing Prostate Cancer Polygenic Risk Scores to the Clinic.
    Klein RJ
    JAMA Intern Med; 2023 Apr; 183(4):388-389. PubMed ID: 36877497
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
    Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
    J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk scores for prostate cancer: testing considerations.
    Toland AE
    Can J Urol; 2019 Oct; 26(5 Suppl 2):17-18. PubMed ID: 31629419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
    Lecarpentier J; Silvestri V; Kuchenbaecker KB; Barrowdale D; Dennis J; McGuffog L; Soucy P; Leslie G; Rizzolo P; Navazio AS; Valentini V; Zelli V; Lee A; Amin Al Olama A; Tyrer JP; Southey M; John EM; Conner TA; Goldgar DE; Buys SS; Janavicius R; Steele L; Ding YC; Neuhausen SL; Hansen TVO; Osorio A; Weitzel JN; Toss A; Medici V; Cortesi L; Zanna I; Palli D; Radice P; Manoukian S; Peissel B; Azzollini J; Viel A; Cini G; Damante G; Tommasi S; Peterlongo P; Fostira F; Hamann U; Evans DG; Henderson A; Brewer C; Eccles D; Cook J; Ong KR; Walker L; Side LE; Porteous ME; Davidson R; Hodgson S; Frost D; Adlard J; Izatt L; Eeles R; Ellis S; Tischkowitz M; ; Godwin AK; Meindl A; Gehrig A; Dworniczak B; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Hauke J; Rhiem K; Kast K; Arnold N; Ditsch N; Wang-Gohrke S; Wappenschmidt B; Wand D; Lasset C; Stoppa-Lyonnet D; Belotti M; Damiola F; Barjhoux L; Mazoyer S; ; Van Heetvelde M; Poppe B; De Leeneer K; Claes KBM; de la Hoya M; Garcia-Barberan V; Caldes T; Perez Segura P; Kiiski JI; Aittomäki K; Khan S; Nevanlinna H; van Asperen CJ; ; Vaszko T; Kasler M; Olah E; Balmaña J; Gutiérrez-Enríquez S; Diez O; Teulé A; Izquierdo A; Darder E; Brunet J; Del Valle J; Feliubadalo L; Pujana MA; Lazaro C; Arason A; Agnarsson BA; Johannsson OT; Barkardottir RB; Alducci E; Tognazzo S; Montagna M; Teixeira MR; Pinto P; Spurdle AB; Holland H; ; Lee JW; Lee MH; Lee J; Kim SW; Kang E; Kim Z; Sharma P; Rebbeck TR; Vijai J; Robson M; Lincoln A; Musinsky J; Gaddam P; Tan YY; Berger A; Singer CF; Loud JT; Greene MH; Mulligan AM; Glendon G; Andrulis IL; Toland AE; Senter L; Bojesen A; Nielsen HR; Skytte AB; Sunde L; Jensen UB; Pedersen IS; Krogh L; Kruse TA; Caligo MA; Yoon SY; Teo SH; von Wachenfeldt A; Huo D; Nielsen SM; Olopade OI; Nathanson KL; Domchek SM; Lorenchick C; Jankowitz RC; Campbell I; James P; Mitchell G; Orr N; Park SK; Thomassen M; Offit K; Couch FJ; Simard J; Easton DF; Chenevix-Trench G; Schmutzler RK; Antoniou AC; Ottini L
    J Clin Oncol; 2017 Jul; 35(20):2240-2250. PubMed ID: 28448241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.
    Mars N; Koskela JT; Ripatti P; Kiiskinen TTJ; Havulinna AS; Lindbohm JV; Ahola-Olli A; Kurki M; Karjalainen J; Palta P; ; Neale BM; Daly M; Salomaa V; Palotie A; Widén E; Ripatti S
    Nat Med; 2020 Apr; 26(4):549-557. PubMed ID: 32273609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer.
    Witte JS; Hoffmann TJ
    OMICS; 2011 Jun; 15(6):393-8. PubMed ID: 21348634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic Risk Scores in Prostate Cancer Risk Assessment and Screening.
    Byrne L; Toland AE
    Urol Clin North Am; 2021 Aug; 48(3):387-399. PubMed ID: 34210493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
    Darst BF; Shen J; Madduri RK; Rodriguez AA; Xiao Y; Sheng X; Saunders EJ; Dadaev T; Brook MN; Hoffmann TJ; Muir K; Wan P; Le Marchand L; Wilkens L; Wang Y; Schleutker J; MacInnis RJ; Cybulski C; Neal DE; Nordestgaard BG; Nielsen SF; Batra J; Clements JA; Cancer BioResource AP; Grönberg H; Pashayan N; Travis RC; Park JY; Albanes D; Weinstein S; Mucci LA; Hunter DJ; Penney KL; Tangen CM; Hamilton RJ; Parent MÉ; Stanford JL; Koutros S; Wolk A; Sørensen KD; Blot WJ; Yeboah ED; Mensah JE; Lu YJ; Schaid DJ; Thibodeau SN; West CM; Maier C; Kibel AS; Cancel-Tassin G; Menegaux F; John EM; Grindedal EM; Khaw KT; Ingles SA; Vega A; Rosenstein BS; Teixeira MR; ; Kogevinas M; Cannon-Albright L; Huff C; Multigner L; Kaneva R; Leach RJ; Brenner H; Hsing AW; Kittles RA; Murphy AB; Logothetis CJ; Neuhausen SL; Isaacs WB; Nemesure B; Hennis AJ; Carpten J; Pandha H; De Ruyck K; Xu J; Razack A; Teo SH; ; Newcomb LF; Fowke JH; Neslund-Dudas C; Rybicki BA; Gamulin M; Usmani N; Claessens F; Gago-Dominguez M; Castelao JE; Townsend PA; Crawford DC; Petrovics G; Casey G; Roobol MJ; Hu JF; Berndt SI; Van Den Eeden SK; Easton DF; Chanock SJ; Cook MB; Wiklund F; Witte JS; Eeles RA; Kote-Jarai Z; Watya S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Am J Hum Genet; 2023 Jul; 110(7):1200-1206. PubMed ID: 37311464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
    Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
    Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer.
    Lello L; Raben TG; Yong SY; Tellier LCAM; Hsu SDH
    Sci Rep; 2019 Oct; 9(1):15286. PubMed ID: 31653892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic health records and polygenic risk scores for predicting disease risk.
    Li R; Chen Y; Ritchie MD; Moore JH
    Nat Rev Genet; 2020 Aug; 21(8):493-502. PubMed ID: 32235907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding polygenic models, their development and the potential application of polygenic scores in healthcare.
    Babb de Villiers C; Kroese M; Moorthie S
    J Med Genet; 2020 Nov; 57(11):725-732. PubMed ID: 32376789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic Risk Scores: What Are They Good For?
    Zheutlin AB; Ross DA
    Biol Psychiatry; 2018 Jun; 83(11):e51-e53. PubMed ID: 29759133
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalisation of genomic findings and applications of polygenic risk scores.
    Corpas M; Fatumo S
    BMC Med Genomics; 2023 Jul; 16(1):175. PubMed ID: 37507694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer PRSweb: An Online Repository with Polygenic Risk Scores for Major Cancer Traits and Their Evaluation in Two Independent Biobanks.
    Fritsche LG; Patil S; Beesley LJ; VandeHaar P; Salvatore M; Ma Y; Peng RB; Taliun D; Zhou X; Mukherjee B
    Am J Hum Genet; 2020 Nov; 107(5):815-836. PubMed ID: 32991828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk for prostate cancer: Decreasing relative risk with age but little impact on absolute risk.
    Schaid DJ; Sinnwell JP; Batzler A; McDonnell SK
    Am J Hum Genet; 2022 May; 109(5):900-908. PubMed ID: 35353984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.